Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.57 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 5/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.44 |
| ▸ | MAPT | P10636 | 5/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29400302 | 1.00 | ACHE (0.63) | ACHETDP1CYP3A4HSD17B10TAAR1 | |
| SCHEMBL4557173 | 0.97 | TDP1 (0.62) | ACHETDP1CYP3A4HSD17B10TAAR1 | |
| SCHEMBL12337342 | 0.95 | TDP1 (0.67) | ACHETDP1CYP3A4HSD17B10TAAR1 | |
| SCHEMBL26262745 | 0.93 | TDP1 (0.71) | ACHETDP1CYP3A4HSD17B10TAAR1 | |
| SCHEMBL21537440 | 0.93 | ACHE (0.57) | ACHETDP1CYP3A4HSD17B10TAAR1 | |
| SCHEMBL19529288 | 0.89 | ACHE (0.58) | ACHETDP1CYP3A4HSD17B10TAAR1 | |
| SCHEMBL25787442 | 0.87 | TDP1 (0.64) | ACHETDP1CYP3A4HSD17B10TAAR1 | |
| SCHEMBL4934597 | 0.85 | MAOA (0.54) | ACHETDP1CYP3A4HSD17B10TAAR1 | |
| SCHEMBL12128618 | 0.84 | ALOX5 (0.55) | ACHETDP1CYP3A4HSD17B10TAAR1 | |
| SCHEMBL20080655 | 0.83 | ALDH1A1 (0.54) | ACHETDP1CYP3A4HSD17B10TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 758 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250333579-A1 | COMPOSITION AND PACKAGE STRUCTURE | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2025-10-30 | — | — | US | claimed |
| US-20250215292-A1 | ADHESIVE AND MULTILAYER STRUCTURE | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2025-07-03 | — | — | US | claimed |
| US-11316094-B2 | Paste composition and preparation method therefor | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2022-04-26 | — | — | US | claimed |
| EP-3101049-B1 | POLYIMIDE AND FILM USING SAME | KOLON INC (KR) | 2020-11-11 | — | — | EP | claimed |
| US-20190181331-A1 | PASTE COMPOSITION AND PREPARATION METHOD THEREFOR | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2019-06-13 | — | — | US | claimed |
| US-10240048-B2 | Corrosion-inhibiting microgels and non-chromated primer compositions incorporating the same | CYTEC INDUSTRIES INC. (US) | 2019-03-26 | — | — | US | claimed |
| US-9829747-B2 | Liquid crystal display panel and method of manufacturing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-11-28 | — | — | US | claimed |
| EP-2938682-B1 | CORROSION-INHIBITING MICROGELS AND NON-CHROMATED PRIMER COMPOSITIONS INCORPORATING THE SAME | CYTEC IND INC (US) | 2017-05-31 | — | — | EP | claimed |
| US-9657140-B2 | Polyimide and film using same | KOLON INDUSTRIES, INC. (KR) | 2017-05-23 | — | — | US | claimed |
| US-20160369054-A1 | POLYIMIDE AND FILM USING SAME | KOLON INDUSTRIES, INC. (KR) | 2016-12-22 | — | — | US | claimed |
| EP-0540829-B1 | Novel liquid crystal alignment treating agent | NISSAN CHEMICAL IND LTD (JP) | 1997-02-26 | — | — | EP | claimed |
| EP-0527439-B1 | Alignment treating agent for liquid crystal cell | NISSAN CHEMICAL IND LTD (JP) | 1996-05-29 | — | — | EP | claimed |
| EP-0361377-B1 | Pervaporation method of separating liquid organic compound mixture through aromatic imide polymer asymmetric membrane | UBE INDUSTRIES (JP) | 1995-06-28 | — | — | EP | claimed |
| US-5399655-A | Acid-labile poly(amic acetal ester) | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-03-21 | — | — | US | claimed |
| US-5350539-A | Alignment treating agent for liquid crystal cell | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1994-09-27 | — | — | US | claimed |
| US-5298590-A | Polyamide resin consisting diamine including aromatic diamine having at least one linear alkyl group | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1994-03-29 | — | — | US | claimed |
| EP-0540829-A1 | Novel liquid crystal alignment treating agent | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1993-05-12 | — | — | EP | claimed |
| EP-0527439-A1 | Alignment treating agent for liquid crystal cell | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1993-02-17 | — | — | EP | claimed |
| US-4959151-A | Pervaporation method of separating liquid organic compound mixture through aromatic imide polymer asymmetric membrane | UBE INDUSTRIES (JP) | 1990-09-25 | — | — | US | claimed |
| EP-0361377-A2 | Pervaporation method of separating liquid organic compound mixture through aromatic imide polymer asymmetric membrane | UBE INDUSTRIES, LTD. (JP) | 1990-04-04 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10240048-B2 | Corrosion-inhibiting microgels and non-chromated primer compositions incorporating the same | PCNA, MCM5, MCM3 | ACHE 74/4885TDP1 1894/4885CYP3A4 1745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.